Filing Details
- Accession Number:
- 0001209191-20-050031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-10 18:21:34
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-10 18:21:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623526 | Stoke Therapeutics Inc. | STOK | Pharmaceutical Preparations (2834) | 471144582 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1780085 | M. Huw Nash | C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730 | Coo & Cbo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-08 | 30,718 | $2.19 | 30,718 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-08 | 30,718 | $30.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-09-09 | 17,201 | $2.19 | 17,201 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-09 | 17,201 | $30.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-09-08 | 30,718 | $0.00 | 30,718 | $2.19 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-09-09 | 17,201 | $0.00 | 17,201 | $2.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 178,812 | 2018-12-12 | No | 4 | M | Direct | |
| 161,611 | 2018-12-12 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
Billionaire Hedge Funds
